...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** BETonMACE Phase 3 Cardio Outcomes Trial for Apabetalone Has Reached its Targeted 250 MACE Events ** Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Free
Message: Objectivity requires facts....we don't have them all yet

Like last April when the PPS plunged about 27% after the company announced THAT share offering.....right now we don't have all the facts.

We have some facts, the offering is being priced at $4, okay.  Anyone want to buy shares through B&B at $4 when they're trading around $3.50 on the open market?  

Did the price get hammered because of fears of trial failure?  Or was it because of massive borrowing and dumping of shares?  Last April bears ended up failing to deliver something like 1 million of the shares they'd dumped into the market....

We'll have more facts next week.....right now, I'm a buyer based on what I know and believe.  Hope that doesn't bother anyone :-)

 

Share
New Message
Please login to post a reply